STIM
Neuronetics, Inc. News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 1,
"returned": 1,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "96234a42-f4a3-40f5-a668-a8d5c46ef30d",
"title": "GREENBROOK TMS REPORTS FIRST QUARTER OPERATIONAL AND FINANCIAL RESULTS",
"description": "TORONTO, May 14, 2024 /PRNewswire/ - Greenbrook TMS Inc. today announced its first quarter 2024 operational and financial results. All values in this news release are in United States dollars,...",
"keywords": "Markets",
"snippet": "TORONTO, May 14, 2024 /PRNewswire/ - Greenbrook TMS Inc. (OTCQB: GBNHF) (\"Greenbrook\" or the \"Company\") today announced its first quarter 2024 (\"Q1 2024\") opera...",
"url": "https://www.marketscreener.com/quote/stock/GREENBROOK-TMS-INC-47342203/news/GREENBROOK-TMS-REPORTS-FIRST-QUARTER-OPERATIONAL-AND-FINANCIAL-RESULTS-46723768/",
"image_url": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
"language": "en",
"published_at": "2024-05-14T21:33:08.000000Z",
"source": "marketscreener.com",
"relevance_score": null,
"entities": [
{
"symbol": "STIM",
"name": "Neuronetics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 22.285614,
"sentiment_score": 0.2824,
"highlights": [
{
"highlight": "of indebtedness; risks related to the ability to continue to negotiate amendments to the Company's credit facility to prevent a default; risks relating to the Company's ability to deliver and execute on the Restructuring Plan and the possible failure to complete the Restructuring Plan on terms acceptable to the Company or its suppliers (including <em>Neuronetics</em>",
"sentiment": 0.2732,
"highlighted_in": "main_text"
},
{
"highlight": ", <em>Inc</em>.), or at all; risks relating to maintaining an active, liquid and orderly trading market for the Common Shares as a result of our delisting from trading on the Nasdaq Capital Market of the Nasdaq Stock Market LLC; risks relating to the Company's ability to realize expected cost-savings and other anticipated benefits from the Restructuring Plan",
"sentiment": 0.6808,
"highlighted_in": "main_text"
},
{
"highlight": "activities and strategic initiatives, or selling assets, other strategic transactions and/or other measures, including obtaining bankruptcy protection, and the terms, value and timing of any transaction resulting from that process; claims made by or against the Company, which may be resolved unfavorably to us; risks relating to the Company's dependence on <em>Neuronetics</em>",
"sentiment": 0.4019,
"highlighted_in": "main_text"
},
{
"highlight": ", <em>Inc</em>. as its exclusive supplier of TMS devices; risks and uncertainties relating to the restatement of our financial statements for the year ended December 31, 2022 and the quarter ended September 30, 2023, including any potential litigation and/or regulatory proceedings as well as any adverse effect on investor confidence and our reputation.",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "STIM",
"total_documents": 1,
"sentiment_avg": 0.2824000120162964
}
]
}
Other details
Exchange
- NASDAQ Stock Exchange
- equity
- Healthcare
- us